Opko Health Inc (OPK)

[tredenwater2]

Crickets.

[game7alcs]

Curious to know who is buying and who is selling right now?

Has there been a form 4 filed by Dr Fishel?

Did Dr Frost buy on the $5 to $3 drop?

Canada, Japan, Europe all give the ok but not the good ol FDA?

Why no announcements of the new contracts BioReference has supposedly gotten per Dr Cohen over the past year?

[game7alcs]

Interesting that he was on the compensation, succession and investment committees. Maybe he completed his work?

Dr. Fishel previously served as a director of the Company since April 2018. At the time of his resignation, Dr. Fishel served on the Compensation Committee and the Succession Committees and was the chair of the Independent Investment Committee of the Board.

[homeboy]

I’m looking at support of 3. There may be a lower trading range being established. If it closes below 3 then there will be more downside ahead.

The revenue from testing should dry up with the government rollout and that is a negative. Revenue will decline with that happening. That is never a good thing for investors to hear.

[tredenwater2]

Market drop or not I really cant believe Opko is trading under three bucks again. If Covid didnt moonshot this with all the testing revenue then theres not a pandemic in the world that can save this company.

Something nefarious is still at play here and I think the Fda and other players are involved. This has a tendency to become a problem when companies start to bring in revenue which Opko has been working on for many, many quarters but when you throw hundreds of billions of dollars to a few big dogs, well the playing field becomes unbalanced.

Whens the buyout offer at $8 coming? Frustrated shareholders will jump at it!


Tred

[homeboy]

I got my four government 15 minute Rapid Covid tests yesterday. Took only 4 days. With this in mind, Opko will have little testing to do anywhere.

[homeboy]

[homeboy]

Amen

[tredenwater2]

But there are those with money and power waiting to seize opportunities that care more about money, than lives and health. On both sides...

God will sort out the believers and non believers later. Those that ignore the bible will be held accountable as it is as simple as:

B asic
I nstructions
B efore
L eaving
E arth

Peace!

[homeboy]

Broke through support in the 3.50 area….on a downtrend now.

[Ecomike]

It's way worse than that "conspiracy theorist in me feels that all they would have to do is wink at someone within the FDA and a mysteriously a problem arises with Opko’s application,"

I could write a book on it going back 60 years or more.... But it is also bureaucrat problems sometimes. Folks that can read, or follow directions or make bad assumptions, etc.... and end up tossing a crow bar in the gear box, sometimes with out knowing it.

But there are those with money and power waiting to seize opportunities that care more about money, than lives and health. On both sides...

[game7alcs]

Excellent post!

[game7alcs]

I Agree

[Ecomike]

LOL, so the drop the ask 20% to a near 1/2 off the target price?

January 24 2022 - 08:15AM
TipRanks
Alert
Print
Tweet Share On Facebook
In a report released today, Michael Petusky from Barrington downgraded Opko Health (OPK – Research Report) to Hold. The company's shares closed last Friday at $4.24. According to TipRanks.com, Petusky is a 4-star analyst with an average return of 8.4% and a 49.0% success rate. Petusky covers the Healthcare sector, focusing on stocks such as Merit Medical Systems, ATI Physical Therapy, and US Physical Therapy. Currently, the analyst consensus on Opko Health is a Moderate Buy with an average price target of $6.75.
https://www.tipranks.com/news/blurbs/analyst-explains-why-they-downgraded-their-rating-on-opko-health-opk?utm_source=advfn.com&utm_medium=referral

[Ecomike]

I have never been a fan of the US FDA, Neither has the US EPA...

Stuff that is bad for people and outlawed in Europe is permitted in the US, where money talks....and peasants walk..

While we need the FDA, everyone knows it needs a make over.

But there will always be a struggle between power and Big money fighting over control......

[game7alcs]

I agree it’s oversold. It’s going to go where the manipulators want it to be. Soma should be approved when the dust settles and the shorts will have covered and bought in cheap. It’s a corrupt world.

[Ecomike]

This dip looks way over done to me. Way too many irons in the fire here, and huge progress the last 2 years to be tossing this one to the side of the road IMO.

$OPK

Gotta love half off Panic sales on profitable revived Covid19 testing and drug company Biotech

[mojo joyo]

I bought a while ago at $3.58. And is back to almost at same price again almost a year ago. Im out soon markets open at least I break even. This ticker I see is not what I was thinking. Not a good investment. My opinion

[tredenwater2]

Yes the FDA and the NIH can now make decisions about our lives by unelected officials that take away our freedoms given by our constitution. Ive never cared or trusted Pfizer as a partner even though the shoe fit their foot. The current never ending money flow between our gov and Pfizer, Moderna (gates foundation) and a few other players are reaping thousands of dollars per minute world wide for these vaccines with a no bid “emergency use authorisation” contract behind closed doors….do you think there is not a “ few” million thrown into a pressure cooker crew to keep this going?

My rambling point is, imo Pfizer has grown too powerful and the conspiracy theorist in me feels that all they would have to do is wink at someone within the FDA and a mysteriously a problem arises with Opko’s application, even though Pfizer is handling it. Stock drops and bad for Opko, good for whoever wants to partner or is thinking about trying to buy them. Now I understand more why flFrost wanted to try to get to 51% of controlling interest for cases just like this.

Also, do you remember a few years back when Rayaldee was getting ready to be approved and their was a “labelling” issue that caused major delays which as a result caused the stock to crater? How does that happen after a decade of research and preparation, a flippin label of all things!

Too many unpredictable forces behind the scenes in Pharma world and the power is concentrating and surfaces one social issue at a time. One safety concern by Fauci with a stroke of a pen sends hundreds of billions of gov funds flooding into a segment of biotech.

Not happy in saying it but we need Trump back!

[game7alcs]

There has to be some real animosity with Dr Frost or something.. There was a time where I would have thought well if the US finds something wrong there must be. Not so much anymore.

[kzivann]

News finally moved OPK. How can there be approvals in Japan, Canada, EU but in the USA?

[tredenwater2]

After hours on a Friday, perfect time to drop bad news! What I dont understand is why the rest of the world is approving this drug but from the looks of it apparently the FDA isnt?

I know they are a bunch of crooks but what n the hell gives here?

https://ih.advfn.com/stock-market/NASDAQ/opko-health-OPK/stock-news/87077344/pfizer-and-opko-provide-update-on-the-biologics-li

[nbm16yankees]

Pfizer, OPKO Health Report FDA Issued Complete Response Letter For Biologics License Application For Their Somatrogon
4:30 pm ET January 21, 2022 (Benzinga) Print

Pfizer Inc. (NYSE:PFE) and OPKO Health, Inc. (NASDAQ:OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for somatrogon. Somatrogon is an investigational once-weekly long-acting recombinant human growth hormone for the treatment of growth hormone deficiency (GHD) in pediatric patients. Pfizer is evaluating the FDA’s comments and will work with the agency to determine an appropriate path forward.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220121005474/en/

“We remain confident in the potential treatment benefits that somatrogon has to offer patients around the world,” said Brenda Cooperstone, MD, Chief Development Officer, Rare Disease, Pfizer Global Product Development. “We will work closely with the FDA to determine the best path forward to bring this important once-weekly treatment option to pediatric growth hormone deficiency patients and their families.”

Regulatory applications for somatrogon have been submitted to several countries around the world for review. Earlier this week, Japan’s Ministry of Health, Labour and Welfare approved NGENLA® (somatrogon) Inj. 24 mg Pens and 60mg Pens, for the long-term treatment of pediatric patients who have growth failure due to an inadequate secretion of endogenous growth hormone. In 2021, Health Canada approved NGENLA® for the long-term treatment of pediatric patients who have GHD, and Australia’s Therapeutic Goods Administration (TGA) approved NGENLA® for the long-term treatment of pediatric patients with growth disturbance due to insufficient secretion of growth hormone. Furthermore, in December 2021, the Committee for Medicinal Products for Human Use (CHMP) of EMA issued a positive opinion recommending somatrogon for marketing authorization in the EU, to treat children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone. A decision from the European Commission (EC) is expected in early 2022.

In 2014, Pfizer and OPKO entered into a worldwide agreement for the development and commercialization of somatrogon for the treatment of GHD. Under the agreement, OPKO is responsible for conducting the clinical program and Pfizer is responsible for registering and commercializing the product for GHD.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

[kzivann]

Approvals in USA and EU looks almost guaranteed and Japan market is large. Thought would be up a good bit.

OPK

[game7alcs]

Yea I’m not sure what will move this. Second largest market and no big deal.

[kzivann]

Great approval news. SP not reacting much. More approval news soon and testing keeps going.

OPK

[game7alcs]

Japan’s MHLW Approves Pfizer and OPKO’s NGENLA® (Somatrogon), a New Long-Acting Treatment for Pediatric Growth Hormone Deficiency

[game7alcs]

I don’t see a buyout now. I think there will be one sometime in the future. They need to get things lined up for a multi company sale for each of their divisions. Just my opinion.

[tredenwater2]

First time Iam up on my reentry shares, took a sale to make it happen during a sector selloff, go figure!

[kzivann]

Nice steady up volume. Is OPK prepping for buyout?

[game7alcs]

I have been saying all along GeneDx was a big deal. I think this is a good deal. It will flourish out from under this management team (not including Dr Cohen). OPKO will still benefit realty from its future earnings.

[kzivann]

News. "Sema4 will acquire GeneDx for an upfront payment of $150 million in cash plus 80.0 million shares in Sema4, with up to an additional $150 million revenue-based milestones over the next two years"


OPK

[game7alcs]

https://apple.news/AXtvXEZyfQ-CJPYEy2eDE8A

[game7alcs]

I thought that was a pretty decent conference call. I had audio only so didn’t see the normal childish behavior with Rubin and Logal. Like I have said before, GeneDx is a lot bigger than it gets credit for. Possible Soma approval at the end of this month in US and Japan was interesting. We would have the Japan market to ourselves for a year or two. All in all a decent amount of good information.

[kzivann]

Market red.. OPK green. Approval soon for Somatrogon.

OPK

[hang on]

Can't wait for weds afterhours this should start to run hard..

[game7alcs]

I didn’t see that.. interesting

[tredenwater2]

No problem, just give me a wink and I will oblige!

Man, did you catch that empire state building buy candle at the end?

[tredenwater2]

No problem, just give me a wink and I will oblige!

Man, did you catch that empire state building buy candle at the end?

[game7alcs]

lol nice job.. I decided to buy some options on this drop so maybe I will be thanking you. lol we will see

[tredenwater2]

Sorry Game, I bought some shares a few days back and caused the drop;( happens everytime!

[game7alcs]

It should be. When? who knows? Could be this month this year? Get rid of Logal and Ruben and it will jump quickly

[Outcast27]

Think OPK will be a winner...Need to grab some.....Soon..

[mojo joyo]

Finally OPK broke the spell and is trading above 5 with latest news release i been holding this for a while at $3.58 avg. Hope the uptrend will continued. This ticker is so hard to figure out. Lots of potential but always price keeps tanking. Lets see this time around

[kzivann]

Up premarket.. slow and steady rise. Not time for a flip.

OPK

[hang on]

Look at my last post just before thanksgiving on 11/18!! Hate to say I told you so, new year is going to give real longs big smiles!! We as trump once said, will get sick of all the winning:) Big News coming in the very near future and beyond.... Keep Smiling And Laughing

[tredenwater2]

Last time I saw this stock rise like this was back in 2012. Made my first silver purchase off profits. The big difference here is there is increasing revenue and possible approval. Also there is 700 less posts per week on a message board pumping Dr. Frost and his purchases. Almost exactly a decade later the stock is again at the $5 level.

I hope for those that have been catching this falling knife that Dr. Frost comes through on his word and provides a return for investors outside of his “group”.

[kzivann]

Another green day. Solid volume and graduall pps rise. Soma approval soon and increase revs.

OPK

[game7alcs]

I think ppl are thinking the chances for a buyout are increasing and FDA approval for Somatrogon should be in Jan. Covid testing is at a peak again. No buyout announced in the next few months the price will drop again IMO.

[kzivann]

Strange is the PPS is going up...Usually, forced down after good PR.

OPK